Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Robin Howard W, Chairman & CEO. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 32 reports have been recorded. Split: 0 buy · 23 sells. Total volume traded: €1.1m. Activity tracked since 17 May 2021. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Robin Howard W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
ROBIN HOWARD W is Président-Directeur Général and is associated with NEKTAR THERAPEUTICS, where he is President & CEO. The declarant has 31 filings in total, and the 31 sampled filings, between 2016-01-21 and 2026-02-20, show only sales for a total of EUR 1,041,859.